Back to search

Caeruleus Genomics Ltd

14481675

active
Private Limited Company
Companies House
Health Score
90 / 100

Healthy

30/30
Filing
20/30
Financial
40/40
Risk

No risk factors detected.

Details

BIOESCALATOR INNOVATION BUILDING, OXFORD, OX3 7FZ
Incorporated 14/11/2022

Compliance

Accounts

Up to date

Confirmation statement

Up to date

Industry

72110
Research and experimental development on biotechnology

Officers

Dr Peter Kirk Crane

director · Since 14/11/2022

ENTREPRENEUR

BRITISH · ENGLAND · Age 37

Prof Adam Paul Cribbs

director · Since 14/11/2022

SCIENTIST

BRITISH · UNITED KINGDOM · Age 39

Prof Udo Oppermann

director · Since 14/11/2022

SCIENTIST

GERMAN · ENGLAND · Age 67

Dr Martin Philpott

director · Since 14/11/2022

SCIENTIST

NEW ZEALANDER · ENGLAND · Age 55

Mr James Oliver Macfarlane

director · Since 13/12/2022

VENTURE CAPITALIST

BRITISH · ENGLAND · Age 38

Also on 1 other board

CompanyRankvs 385+ SIC 72110 peers
76

Financial strength92th percentile among SIC peers · 23/25
Employees94th percentile among SIC peers · 14/15
LiquidityCurrent ratio 27.53× · 20/20
Longevity4 years trading (max 15) · 4/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
How is this score calculated?
Financial strength23/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees14/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity20/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity4/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 30/11/2025

Net Worth

£922k

Balance sheet strength

Cash

£595k

Cash in the bank

Net Current Assets

£862k

Working capital

Current Assets

£894k

Current Liabilities

£32k

Fixed Assets

£60k

Debtors

£300k

13avg. employees+8

Balance Sheet

Assets less current liabilities£922k
Prepared with Caseware UK (AP4) 2024.0.164

EstimatesDerived

YearCurrent RatioImplied Profit
202527.53+£999k
20240.95

Derived from filed accounts. Not audited figures.